Navigation Links
Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
Date:9/5/2013

ly provide physicians with a transformative new option for pain management. The rapid progress made by the Adynxx team brings AYX1 one step closer to meeting the needs of millions of patients who every year suffer from pain after surgery."

About Adynxx

Adynxx, located in San Francisco, California, is a clinical-stage pharmaceutical company developing a transformative technology platform addressing pain at its molecular roots - preventing the development of pain following surgery or trauma and resolving established chronic pain syndromes.  Adynxx's unique approach is to transform pain management by approaching pain as a disease rather than a symptom.

Adynxx's lead compound, AYX1, is an investigational drug designed to reduce acute post-surgical pain and prevent the transition to persistent or chronic pain with a single administration at the time of surgery. 

Funded by Domain Associates, Adynxx has successfully completed a Phase 1 clinical study of AYX1 and completed enrollment in a Phase 2 study of AYX1 in Q3 2013.  Additional compounds targeting a range of intractable neuropathic and inflammatory pain syndromes are in the pre-clinical discovery stage.

Media Contact:

David Schull or Ian Stone
Russo Partners
(858) 717-2310
(619) 308-6541
david.schull@russopartnersllc.com
ian.stone@russopartnersllc.com


'/>"/>
SOURCE Adynxx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
2. Lead Therapeutic Candidate for Treatment of Pain from Adynxx, AYX1, Well-Tolerated in Phase 1 Clinical Study
3. Adynxx Completes Enrollment in Phase 1 Clinical Study of Lead Therapeutic for Treatment of Pain, AYX1
4. Otonomy Completes $45.9 Million Series C Equity Financing
5. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
6. SERVE-HF; the Worlds Largest Study of Sleep-Disordered Breathing in Heart Failure Completes Recruitment
7. OPKO Completes Acquisition Of PROLOR Biotech
8. Sleep Nation, Inc. Completes 43 Acquisitions
9. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
10. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
11. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... EDINBURGH, Scotland , July 1, 2015 ... joins Nu C ana team   ... proprietary ProTide technology to develop and commercialise a portfolio ... Professor Chris McGuigan as Chief Scientific Officer. ... the ProTide technology. He is currently Professor of Medicinal ...
(Date:6/30/2015)... 2015 Ansell, a global leader ... of the first Ansell Cares ® H.E.R.O. ... The 2015 award, organised in partnership with the European ... display exceptional skill and quality in patient care, and ... Award ceremonies are taking place today in the winners, ...
(Date:6/30/2015)... Calif. , June 30, 2015  The MEDevice ... consecutive year, is an event dedicated to bringing medtech ... hottest issues and topics affecting the industry today. This ... address the challenges and opportunities facing today,s medtech professional ... information and to register for MEDevice San Diego, please ...
Breaking Medicine Technology:Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2
... ROCKVILLE, Md., Feb. 18, 2011 Novavax, Inc. ... today presented the final safety and immunogenicity results from ... clinical trial in Mexico at the invitation-only 7th World ... Vaccines in Clinical Trials. The meeting was held at ...
... Feb. 18, 2011 FUJIFILM Medical Systems ... footprint mobile application enabling remote access to ... as well as Macintosh- or Windows-based PCs.  Differentiated from ... quality, interactive three dimensional medical images in any platform ...
Cached Medicine Technology:NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5Fujifilm's Synapse® Mobility Extends Imaging Reach 2
(Date:6/30/2015)... ... July 01, 2015 , ... Carey Danis & ... being managed in a West Virginia federal court. The court document outlined the ... date for the 26 cases.¹ , Carey Danis & Lowe is a personal injury ...
(Date:6/30/2015)... Detroit, MI (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable ... The 44-year-old native of Detroit, MI, Kid Rock, is hitting the road again this summer ... rock, country, and hip hop superstar kicked off his summer tour this year at the ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Texas have launched a ‘responsive design’ website to inform potential sinus surgery patients ... them. , The website includes information about a wide variety of ENT issues ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to announce it’s own Debby Mann, CPC, RCC, ROCC, Coding Documentation and Education ... with the Special Recognition Award for her contribution to the RBMA Coding Subcommittee. ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... in a new video, “Grand Terrace Health Care Center.” Each year, Medicare ranks ... help patients find the best facility for their needs. Grand Terrace prides itself ...
Breaking Medicine News(10 mins):Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2
... small amount of smoke found in the environment can have ... a healthy school child. Even a small quantity of ... relying on the smoking habits of the parents and nears ... artery (located in the arm) function of 402 children, age ...
... old resident in New York, drank Boost Plus, a vitamin enriched ... ,When he woke up the next day, he had ... for medical advice and for treatment of the condition called severe ... is persistent, painful erection of the penis. Recurrent or severe episodes ...
... revealed that the prison population in England and Wales reached ... that there were fewer than 300 cells available for new ... cells to house prisoners in some areas of the country. ... of the BMAs Civil and Public Services Committee said: ...
... to iodine-containing contrast agents ,according to a recent study ... Center and C.S. Mott Childrens Hospital both in ... risk associated with iodine-containing contrast agents is allergic types ... hives or severe such as difficulty breathing or even ...
... a leading developer and manufacturer of a broad ... the launch of a new, higher power Smartlipo ... is intended for high-volume aesthetic laser practices, allowing ... procedure in about half the time as the ...
... Inc. (OTC Bulletin Board: IFLG), a leading provider of ... America, was identified today as one of the ... list of top companies by healthcare IT revenue. ... a 22 point jump over the previous year. InfoLogix's ...
Cached Medicine News:Health News:Prison Healthcare Under Strain as Overcrowding Crisis Worsens, Warns BMA 2Health News:Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation 2Health News:InfoLogix, Inc. the Leading Healthcare Technology Company SaysHealthcare Informatics 2
... low density lipoprotein cholesterol (LDL-C) ... stable, ready-to-use reagent. Selective direct ... Excellent correlation with established reference ... Available with Calibrator: Trucal HDL/LDL ...
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: 3.5 - 7.0 mg/dL. Available with calibrator and number of test 125....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
For the quantitative determination of uric acid in serum....
Medicine Products: